TSH immunoassays and processes for performing TSH immunoassays in the presence of endogenous contaminants in restricted wash formats

• US 9,201,078 B2
• Filed: 11/29/2011
• Issued: 12/01/2015
• Est. Priority Date: 05/27/2011
• Status: Active Grant

• Current Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Wang, Dan, Collier, Gordon Bruce, Skinner, Joseph P., Ruan, Qiaoqiao, Tetin, Sergey Y.
• Primary Examiner(s): Gabel, Gail R
• Assistant Examiner(s): GRUN, JAMES LESLIE
• Application Number:
  US13/306,536
• Publication Number:
  US 20120301905A1
• Time in Patent Office: 1,463 Days
• Field of Search: 422/401, 422/403, 422/408, 422/412, 422/414, 422/417, 422/425, 422/82.01, 435/7.94, 435/283.1, 435/285.2, 435/287.2, 435/287.9, 435/288.3, 435/288.4, 435/288.5, 436/501, 436/514, 436/518, 436/524, 436/525, 436/528, 436/534, 436/548, 530/388.24, 530/389.2, 530/391.1, 530/391.3
• US Class Current: 1/1
• CPC Class Codes: B01L 3/50273 characterised by the means or forces applied to move the fluids micropumps F04B19/006, of the membrane type F04B43/043
• CPC Class Codes: B01L 3/502738 characterised by integrated valves microvalves F16K99/0001
• CPC Class Codes: C07K 16/26 against hormones ; against hormone releasing or inhibiting factors
• CPC Class Codes: C07K 2317/33 Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
• CPC Class Codes: G01N 2333/59 Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
• CPC Class Codes: G01N 33/5302 Apparatus specially adapted for immunological test procedures
• CPC Class Codes: G01N 33/543 with an insoluble carrier for immobilising immunochemicals
• CPC Class Codes: G01N 33/74 involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
• CPC Class Codes: G01N 33/76 Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Abstract

The invention relates to low wash Thyroid Stimulating Hormone (TSH) immunoassays using an ELISA sandwich assay having limited or no wash step between the antigen capture, detection antibody addition and substrate introduction steps. This invention exhibits low cross reactivity with biologically similar interfering cross reacting species, such as Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH) and Chorionic Gonadotropin (CG).

Claims

1. A method for performing a thyroid stimulating hormone (TSH) immunoassay, the method comprising the steps of:

(a) inserting a fluid sample into a device comprising an immunosensor in a conduit, said immunosensor having a capture antibody specific for TSH immobilized thereon;

(b) dissolving a signal antibody into said fluid sample;

(c) forming a sandwich complex on said immunosensor, said complex comprising said capture antibody, TSH from the fluid sample, and said dissolved signal antibody;

(d) washing uncomplexed signal antibody and fluid sample from the immunosensor with a wash fluid in no more than one washing step; and

(e) detecting a signal associated with said complexed signal antibody as indicative of a level of TSH in the fluid sample;

wherein the capture antibody and the signal antibody are epitope-compatible antibodies;

wherein the capture antibody and the signal antibody, respectively, are capable of binding to at least two different epitopes on a TSH-β

subunit of TSH;

wherein the capture antibody and the signal antibody each have a dissociation constant (Kd) for TSH;

wherein the capture antibody Kd for follicle stimulating hormone (FSH), luteinizing hormone (LH) and chorionic gonadotropin (CG) is in the range of from 70 to 1000 nM, 35 to 1000 nM and 40 to 500 nM, respectively;

wherein the signal antibody Kd for FSH, LH and CG is in the range of from 70 to 300 nM, 35 to 54 nM and 40 to 45, respectively;

wherein the capture antibody Kd for FSH, LH and CG is greater than the signal antibody Kd for FSH, LH and CG; and

wherein the capture antibody comprises mouse monoclonal anti-TSH-β

antibody 5409 and the signal antibody comprises mouse monoclonal anti-TSH-β

antibody M94206.

2. The method of claim 1, wherein the capture antibody has a first Kd ratio, Kd(FSH):

Kd(TSH), that is in the range of from 1500 to 10000, and the signal antibody has a second Kd ratio, Kd(FSH);

Kd(TSH), that is in the range of from 1500 to 3750.

3. The method of claim 1, wherein the sandwich complex is formed by substantially non-sequential contact of said capture and signal antibodies with the fluid sample.

4. The method of claim 1, wherein the sandwich complex is formed without one or more intervening wash steps directed to ameliorating a cross reaction with one or more of FSH, LH or CG.

5. The method of claim 1, wherein the fluid sample is a diluted blood sample, an undiluted blood sample, a diluted plasma sample, or an undiluted plasma sample.

6. The method of claim 1, wherein the capture antibody is covalently bound to a bead.

7. The method of claim 1, wherein the signal antibody is conjugated to a reporter molecule selected from the group consisting of alkaline phosphatase, horseradish peroxidase and a fluorescent moiety.

8. The method of claim 1, wherein the detecting step is electrochemical.

9. The method of claim 1, wherein the detecting step is optical.

10. The method of claim 1, wherein the wash fluid also comprises a substrate for a reporter molecule.

11. The method of claim 1, further comprising metering the fluid sample in a metering chamber to form a metered sample having a volume of from 1 to 500 μ

L.

12. The method of claim 1, further comprising bursting a wash fluid pouch, which is in fluid communication with the immunosensor, to release from 5 to 500 μ

L of wash fluid into said conduit for the washing step (d).

13. The method of claim 1, further comprising forming a plurality of air segments in said wash fluid.

14. A method for performing a thyroid stimulating hormone (TSH) immunoassay, the method comprising the steps of:

(a) inserting a fluid sample into a device comprising an immunosensor in a conduit, said immunosensor having a capture antibody specific for TSH immobilized thereon;

(b) dissolving a signal antibody into said fluid sample;

(c) forming a sandwich complex on said immunosensor, said complex comprising said capture antibody, TSH from the fluid sample, and said dissolved signal antibody;

(d) washing uncomplexed signal antibody and fluid sample from the immunosensor with a wash fluid in no more than one washing step; and

(e) detecting a signal associated with said complexed signal antibody as indicative of a level of TSH in the fluid sample;

wherein the capture antibody and the signal antibody are epitope-compatible antibodies;

wherein the capture antibody and the signal antibody, respectively, are capable of binding to at least two different epitopes on a TSH-β

subunit of TSH;

wherein the capture antibody and the signal antibody each have a dissociation constant (Kd) for TSH;

wherein the capture antibody Kd for follicle stimulating hormone (FSH), luteinizing hormone (LH) and chorionic gonadotropin (CG) is in the range of from 70 to 1000 nM, 35 to 1000 nM and 40 to 500 nM, respectively;

wherein the signal antibody Kd for FSH, LH and CG is in the range of from 70 to 300 nM, 35 to 54 nM and 40 to 45, respectively;

wherein the capture antibody Kd for FSH, LH and CG is greater than the signal antibody Kd for FSH, LH and CG; and

wherein the capture antibody comprises mouse monoclonal anti-TSH-β

antibody 5409 and the signal antibody comprises mouse monoclonal anti-TSH-β

antibody Ab9390.